» Articles » PMID: 37026253

A Review of Rabbit Models of Meibomian Gland Dysfunction and Scope for Translational Research

Overview
Specialty Ophthalmology
Date 2023 Apr 7
PMID 37026253
Authors
Affiliations
Soon will be listed here.
Abstract

Dry eye disease (DED) is an emerging global health concern with meibomian gland dysfunction (MGD) being the most common subtype of DED. Despite being quite prevalent, the pathophysiological mechanisms governing MGD are poorly understood. Animal models for MGD can be a valuable resource to advance our understanding of this entity and explore novel diagnostic and therapeutic modalities. Although a lot of literature on rodent MGD models exists, a comprehensive review on rabbit animal models is lacking. Rabbits offer a great advantage over other animals as models for studying both DED and MGD. Rabbits have a widely exposed ocular surface and meibomian gland anatomy comparable with humans, which makes performing dry eye diagnostic tests possible using clinically validated imaging platforms. The existing MGD models in rabbits can broadly be classified as pharmacologically induced and surgically induced models. Most models show keratinization of the meibomian gland orifice with plugging as the final common pathway for developing MGD. Thus, understanding the advantages and disadvantages of each rabbit MGD model can help researchers choose the appropriate experimental plan based on the objective of the study. In this review, we discuss the comparative anatomy of the meibomian glands in humans and rabbits, various rabbit models of MGD, translational applications, unmet needs, and future directions in developing MGD models in rabbits.

Citing Articles

A Novel Rabbit Model of Meibomian Gland Dysfunction-Induced Dry Eye.

Gallois-Bernos A, Zhong L, Bai M, Blackie C Transl Vis Sci Technol. 2025; 14(1):28.

PMID: 39878702 PMC: 11781322. DOI: 10.1167/tvst.14.1.28.


Alkali burn injury model of meibomian gland dysfunction in mice.

Li Y, Yang Y, Lin Y, Yan K, Lyu Y, Zhang Z Int J Ophthalmol. 2024; 17(12):2158-2166.

PMID: 39697880 PMC: 11589446. DOI: 10.18240/ijo.2024.12.02.


Recent advances in age-related meibomian gland dysfunction (ARMGD).

Moreno I, Verma S, Gesteira T, Coulson-Thomas V Ocul Surf. 2023; 30:298-306.

PMID: 37979775 PMC: 11092925. DOI: 10.1016/j.jtos.2023.11.003.


Seeing through tears: Understanding and managing dry eye disease.

Basu S Indian J Ophthalmol. 2023; 71(4):1065-1066.

PMID: 37026232 PMC: 10276686. DOI: 10.4103/IJO.IJO_642_23.

References
1.
. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5(2):163-78. DOI: 10.1016/s1542-0124(12)70085-x. View

2.
Harvey D, Tiffany J . Identification of meibomian gland lipids by gas chromatography-mass spectrometry: application to the meibomian lipids of the mouse. J Chromatogr. 1984; 301(1):173-87. DOI: 10.1016/s0021-9673(01)89187-1. View

3.
Vinas M, Maggio F, DAnna N, Rabozzi R, Peruccio C . Meibomian gland dysfunction (MGD), as diagnosed by non-contact infrared Meibography, in dogs with ocular surface disorders (OSD): a retrospective study. BMC Vet Res. 2019; 15(1):443. PMC: 6896755. DOI: 10.1186/s12917-019-2203-3. View

4.
Greiner J, Glonek T, Korb D, Whalen A, Hebert E, Hearn S . Volume of the human and rabbit meibomian gland system. Adv Exp Med Biol. 1998; 438:339-43. DOI: 10.1007/978-1-4615-5359-5_48. View

5.
Fraunfelder F, LaBraico J, Meyer S . Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol. 1985; 100(4):534-7. DOI: 10.1016/0002-9394(85)90676-2. View